A novel inhibitor of Rho GDPdissociation inhibitor α improves the therapeutic efficacy of paclitaxel in Lewis lung carcinoma

Author：          

Publisher： Science Publishers

ISSN： 2049-9434

Source： Biomedical Reports, Vol.3, Iss.4, 2015-01, pp. : 473-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma

By Fujita Akihiko  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 137-142

Springer Publishing Company

Access to resources Recommend Favorite

Integrin α5β1: a potent inhibitor of experimental lung metastasis

By Schirner M.   Herzberg F.   Schmidt R.   Streit M.   Schoning M.   Hummel M.   Kaufmann C.   Thiel E.   Kreuser E-D.  

Clinical and Experimental Metastasis, Vol. 16, Iss. 5, 1997-07 ,pp. : 427-435

Springer Publishing Company

Access to resources Recommend Favorite

Reduced expression of Rho GDP dissociation inhibitor 2 mRNA is associated with lymph node metastasis in gastric carcinoma

By                

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 463-467

Spandidos Publications

Access to resources Recommend Favorite

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

By                            

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 2011-2018

Spandidos Publications

Access to resources Recommend Favorite

Interleukin15: A potent adjuvant enhancing the efficacy of an autologous wholecell tumor vaccine against Lewis lung carcinoma

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1828-1834

Spandidos Publications

Access to resources Recommend Favorite